StockData
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.55−0.12 (-1.24%)

Close on Nov 17, 2026Market cap $359.28MP/E –Yield –

Contineum Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Contineum Therapeutics's market cap was $360.31M on Nov 11, 2026, against $292.64M a year earlier. Over the last 3 years it ranged from $36.53M to $543.31M, with a median of $270.02M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$360.31M+19.2%
2025Dec 31, 2025$302.16M+50.8%
2024Dec 31, 2024$200.33M–

More Contineum Therapeutics figures

See a number that looks wrong?